BioLineRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.About BLRX
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors.
CEOPhilip Adam Serlin
CEOPhilip Adam Serlin
Employees24
Employees24
HeadquartersModi'in, HaMerkaz
HeadquartersModi'in, HaMerkaz
Founded2003
Founded2003
Employees24
Employees24
BLRX Key Statistics
Market cap10.50M
Market cap10.50M
Price-Earnings ratio-1.12
Price-Earnings ratio-1.12
Dividend yield—
Dividend yield—
Average volume15.13K
Average volume15.13K
High today$2.11
High today$2.11
Low today$2.04
Low today$2.04
Open price$2.04
Open price$2.04
Volume1.70K
Volume1.70K
52 Week high$3.95
52 Week high$3.95
52 Week low$1.95
52 Week low$1.95
BLRX News
TipRanks 23h
BioLineRx and Hemispherian Report GLIX1–PARP Inhibitor Synergy in HR-Proficient Ovarian CancerBioline RX Ltd Sponsored ADR ( (BLRX) ) has issued an announcement. On October 23, 2026, BioLineRx and Hemispherian reported preclinical data presented at the...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.